Avant GenomicsAvant Genomics
AG

Avant Genomics

Developing an automated platform for liquid biopsy sample preparation.

2021Inactive
Rate

About

Avant Genomics is a startup focused on advancing the development of the Avant Source™, an automated platform designed for liquid biopsy sample preparation. This platform aims to streamline and improve the process of preparing samples for liquid biopsies, which are crucial for non-invasive disease detection and monitoring.

Technology stack

detected 2026-06-15
Est. monthly stack spend~$70/mo
EmailMicrosoft 365
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Avant Genomics do?

Avant Genomics is a startup focused on advancing the development of the Avant Source™, an automated platform designed for liquid biopsy sample preparation. This platform aims to streamline and improve the process of preparing samples for liquid biopsies, which are crucial for non-invasive disease detection and monitoring.

How much funding has Avant Genomics raised?

Avant Genomics has raised a total of $3M in funding. The most recent round on record is Funding Round.

Where is Avant Genomics headquartered?

Avant Genomics is headquartered in Charlottesville, Virginia, USA.

When was Avant Genomics founded?

Avant Genomics was founded in 2021.

What industry does Avant Genomics operate in?

Avant Genomics operates in Biotechnology, Healthcare, Genomics, Diagnostics, Biotech, MedTech.

What is Avant Genomics's current status?

Avant Genomics's current operating status is: Inactive.